Analyst Ratings for Summit Therapeutics plc (SMMT) [Buys]
SMMT Rating Summary
SMMT Price Target Summary
- Highest: $8.00 (Stifel)
- Lowest: $8.00 (Stifel)
- Average: $8.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$8.00 (+128.6%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 53%
Avg. $ Target:
$8.00 (+128.6%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 53%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/26/2024 | Stifel | Brad Canino | New Coverage | Buy (N/A) |
8.00 (N/A) |
3.37 (3.50) |
3.86% | Details |
| 2/13/2018 | BTIG » Updated 6/27/2018 |
N/A | New Coverage | Buy (N/A) |
5.00 (33.00) |
10.80 (3.50) |
-67.59% | Details |
 |
||||||||
|
||||||||
